See also this year's filing and all EDGAR filings for this company.
PDF Report 0001335105_2020_LIXTE_BIOTECHNOLOGY_HOLDINGS_INC.pdf
Logs
warning | Missing logo | subcommand.report | {} |
info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001335105')"} |
Graph
Absolute values for 0001335105, LIXTE BIOTECHNOLOGY HOLDINGS INC.
xvar | xval | |
---|---|---|
0 | AssetsCurrent | 2,672,033 |
1 | IntangibleAssetsNetIncludingGoodwill | 0 |
2 | PropertyPlantAndEquipmentNet | 0 |
3 | remainder_Assets | 0 |
4 | LiabilitiesCurrent | 237,898 |
5 | LiabilitiesNoncurrent | 0 |
6 | remainder_Liabilities | 0 |
7 | CostOfGoodsAndServicesSold | 0 |
8 | SellingGeneralAndAdministrativeExpense | 1,669,160 |
9 | ResearchAndDevelopmentExpense | 820,906 |
10 | remainder_Expenses | 0 |
11 | remainder_Revenues | 0 |
12 | remainder_NetIncome | 49,723 |
13 | remainder_ComprehensiveNetIncome | 0 |
yvar | yval | |
---|---|---|
0 | Assets | 2,672,033 |
1 | Liabilities | 237,898 |
2 | Expenses | 2,490,066 |
3 | Revenues | 0 |
4 | StockholdersEquity | 2,434,135 |
5 | NetIncome | -2,440,343 |
6 | ComprehensiveNetIncome | -2,440,343 |
7 | BaseVar | 2,724,860 |
8 | EconomicCapitalRatio | 1.20 |